- Home
- NEN vs NKTR Comparison
NEN vs NKTR Comparison
Compare NEN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- NKTR
- Stock Information
- Founded
- NEN 1977
- NKTR 1990
- Country
- NEN United States
- NKTR United States
- Employees
- NEN N/A
- NKTR N/A
- Industry
- NEN Building operators
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- NEN Real Estate
- NKTR Health Care
- Exchange
- NEN Nasdaq
- NKTR Nasdaq
- Market Cap
- NEN 262.4M
- NKTR 108.3M
- IPO Year
- NEN N/A
- NKTR 1994
- Fundamental
- Price
- NEN $73.04
- NKTR $25.53
- Analyst Decision
- NEN
- NKTR Strong Buy
- Analyst Count
- NEN 0
- NKTR 6
- Target Price
- NEN N/A
- NKTR $77.50
- AVG Volume (30 Days)
- NEN 856.0
- NKTR 4.5M
- Earning Date
- NEN 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- NEN 6.57%
- NKTR N/A
- EPS Growth
- NEN 58.97
- NKTR N/A
- EPS
- NEN 4.56
- NKTR N/A
- Revenue
- NEN $82,531,485.00
- NKTR $87,248,000.00
- Revenue This Year
- NEN N/A
- NKTR N/A
- Revenue Next Year
- NEN N/A
- NKTR N/A
- P/E Ratio
- NEN $16.01
- NKTR N/A
- Revenue Growth
- NEN 6.12
- NKTR N/A
- 52 Week Low
- NEN $67.50
- NKTR $6.48
- 52 Week High
- NEN $84.00
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- NEN 37.41
- NKTR 70.35
- Support Level
- NEN $73.00
- NKTR $8.27
- Resistance Level
- NEN $73.50
- NKTR $37.38
- Average True Range (ATR)
- NEN 0.34
- NKTR 3.58
- MACD
- NEN 0.00
- NKTR 1.48
- Stochastic Oscillator
- NEN 2.67
- NKTR 59.68
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.